Document Detail


The first infant to survive a generalized BCG infection.
MedLine Citation:
PMID:  6753467     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
A 17-month-old boy who contracted a severe generalized BCG infection is reported. He was treated for 2 years with streptomycin, isoniazide and rifampicin and is now, at the age of 5 years, apparently cured. The boy had an unexplained discrepancy between humoral and cellular PPD reactivity for several years, but conventional immunological studies including plasma immunoglobulin levels, blast transformation as well as MLC reactivity were all normal. This is, to the best of our knowledge, the first child reported who has survived a generalized BCG infection.
Authors:
G Källenius; E Möller; O Ringdén; B Strandvik; P Sundelin
Related Documents :
10631207 - Delays in tuberculosis isolation and suspicion among persons hospitalized with hiv-rela...
10786417 - Commercial polymerase chain reaction test (amplicor set) in the diagnosis of smear-nega...
20563447 - Parasternum pleural-cutaneous fistula in a severely immunosuppressed hiv-positive patient.
20637077 - Smear microscopy and culture conversion rates among smear positive pulmonary tuberculos...
19645607 - Acetylcholine-esterase inhibitor pyridostigmine decreases t cell overactivation in pati...
12295857 - Aids cases rise in china.
Publication Detail:
Type:  Case Reports; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta paediatrica Scandinavica     Volume:  71     ISSN:  0001-656X     ISO Abbreviation:  Acta Paediatr Scand     Publication Date:  1982 Jan 
Date Detail:
Created Date:  1982-12-16     Completed Date:  1982-12-16     Revised Date:  2009-11-11    
Medline Journal Info:
Nlm Unique ID:  0000211     Medline TA:  Acta Paediatr Scand     Country:  SWEDEN    
Other Details:
Languages:  eng     Pagination:  161-5     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antibodies, Bacterial / analysis
B-Lymphocytes / immunology
Child, Preschool
Humans
Infant
Isoniazid / therapeutic use
Lymphocyte Activation
Male
Mitogens / pharmacology
Mycobacterium bovis / immunology
Plaque Assay
Prognosis
Rifampin / therapeutic use
Streptomycin / therapeutic use
T-Lymphocytes / immunology
Tuberculosis / drug therapy*,  immunology
Chemical
Reg. No./Substance:
0/Antibodies, Bacterial; 0/Mitogens; 13292-46-1/Rifampin; 54-85-3/Isoniazid; 57-92-1/Streptomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of glucagon infusion on some plasma metabolites and hormones in obese children.
Next Document:  Metabolic events in infants of diabetic mothers during first 24 hours after birth. I. Changes in pla...